Compare Elder Pharma with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA NATCO PHARMA ELDER PHARMA/
NATCO PHARMA
 
P/E (TTM) x -0.2 15.4 - View Chart
P/BV x 0.1 3.0 3.3% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 ELDER PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
NATCO PHARMA
Mar-18
ELDER PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs3801,080 35.2%   
Low Rs188671 28.0%   
Sales per share (Unadj.) Rs491.2592.1 83.0%  
Earnings per share (Unadj.) Rs-3.2188.4 -1.7%  
Cash flow per share (Unadj.) Rs14.4206.3 7.0%  
Dividends per share (Unadj.) Rs08.25 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs376.5833.6 45.2%  
Shares outstanding (eoy) m20.5436.90 55.7%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x0.61.5 39.1%   
Avg P/E ratio x-89.34.6 -1,920.6%  
P/CF ratio (eoy) x19.74.2 464.5%  
Price / Book Value ratio x0.81.1 71.8%  
Dividend payout %04.4 0.0%   
Avg Mkt Cap Rs m5,83332,311 18.1%   
No. of employees `000NA4.8 0.0%   
Total wages/salary Rs m2,1793,256 66.9%   
Avg. sales/employee Rs ThNM4,522.5-  
Avg. wages/employee Rs ThNM674.0-  
Avg. net profit/employee Rs ThNM1,439.0-  
INCOME DATA
Net Sales Rs m10,08921,848 46.2%  
Other income Rs m257404 63.5%   
Total revenues Rs m10,34622,252 46.5%   
Gross profit Rs m-7929,284 -8.5%  
Depreciation Rs m361662 54.6%   
Interest Rs m2,756154 1,789.8%   
Profit before tax Rs m-3,6538,872 -41.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,920 6.5%   
Profit after tax Rs m-656,952 -0.9%  
Gross profit margin %-7.842.5 -18.5%  
Effective tax rate %-3.421.6 -15.8%   
Net profit margin %-0.631.8 -2.0%  
BALANCE SHEET DATA
Current assets Rs m9,24021,307 43.4%   
Current liabilities Rs m9,9985,920 168.9%   
Net working cap to sales %-7.570.4 -10.7%  
Current ratio x0.93.6 25.7%  
Inventory Days Days4673 63.2%  
Debtors Days Days60107 56.3%  
Net fixed assets Rs m10,12414,986 67.6%   
Share capital Rs m206369 55.7%   
"Free" reserves Rs m5,58230,353 18.4%   
Net worth Rs m7,73430,760 25.1%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88237,151 61.6%  
Interest coverage x-0.358.6 -0.6%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.6 75.0%   
Return on assets %11.819.1 61.5%  
Return on equity %-0.822.6 -3.7%  
Return on capital %22.329.3 76.0%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30710,322 3.0%   
Fx outflow Rs m1252,978 4.2%   
Net fx Rs m1817,343 2.5%   
CASH FLOW
From Operations Rs m11,7544,636 253.5%  
From Investments Rs m-561-11,155 5.0%  
From Financial Activity Rs m-6,7626,509 -103.9%  
Net Cashflow Rs m4,432-18 -24,620.6%  

Share Holding

Indian Promoters % 39.6 52.0 76.1%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 7.5 7.8 95.7%  
FIIs % 16.8 16.6 101.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 26.0 138.8%  
Shareholders   16,479 25,395 64.9%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

What Should You Do in Today's Volatile Markets?(Podcast)

The week gone by was pretty volatile for Dalal street and the global environment is as unpredictable as it can get.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

Small Cap Stocks Could Triple in Less than 2 Years... Here's Why(Profit Hunter)

Sep 30, 2019

Historical data backs up my conviction.

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Sep 30, 2019

Select dividend stocks can be very rewarding.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS